INVENTURUS KNOWLEDGE SOLUTIONS LIMITED — Capital/Financing Update 2025

Oct 16, 2025

October 16, 2025

BSE Limited National Stock Exchange of India Limited The Listing Department The Listing Department Phiroze Jeejeebhoy Towers Exchange Plaza, Plot No. C/1, G Block, 25[th] Floor, Dalal Street Bandra Kurla Complex Fort, Mumbai 400 001 Bandra (East), Mumbai 400051 Maharashtra, India Maharashtra, India

BSE Scrip Code: 544309 NSE Symbol: IKS

Dear Sir/Ma’am,

Subject : Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI LODR Regulations”) – Further investment in Inventurus Knowledge Solutions, Inc., a wholly owned subsidiary.

Pursuant to provisions of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that the Company has made a further investment of USD 10,001,605/- in Inventurus Knowledge Solutions, Inc. (“ IKS Inc ”), a wholly owned subsidiary of the Company.

The relevant disclosure as required under Regulation 30 of the SEBI LODR Regulations read with SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024 is enclosed as Annexure - I .

Kindly take the above-mentioned information on record.

Thanking you,

Yours sincerely

For Inventurus Knowledge Solutions Limited

Sameer Digitally signed by Sameer Shashikant Shashikant Chavan Date: 2025.10.16 18:05:03 Chavan +05'30' Sameer Chavan

Company Secretary and Compliance Officer

Membership No.: F7211

Enclosure: As above

ANNEXURE – I

DISCLOSURE UNDER REGULATION 30 OF THE SEBI LODR REGULATIONS READ WITH SEBI MASTER CIRCULAR NO. SEBI/HO/CFD/POD2/CIR/P/0155 DATED NOVEMBER 11, 2024

Sr. No.	Particulars		Details	Details
1.	Name of the target entity, details in brief such as size, turnover etc.		Inventurus Knowledge Solutions Inc. (“IKS Inc.”) is a wholly owned subsidiary of the Company. IKS Inc. is engaged in providing a care enablement platform which comprises of technology-enabled solutions for healthcare providers . Financial Details of IKS Inc: Particulars Amt in INR Mn FY 2024-25 Revenue from Operations 6,941.11 Other Income 55.81 Total Income 6,996.92
			Particulars	Amt in INR Mn FY 2024-25
			Revenue from Operations	6,941.11
			Other Income	55.81
			Total Income	6,996.92
2.	Whether the acquisition would fall within related party transaction(s) and whether the promoter/ promoter group/ group companies have any interest in the entity being acquired? If yes, nature of interest and details thereof and whether the same is done at "arm’s length"		IKS Inc is a wholly owned subsidiary of the Company and therefore related party, and a transaction is on an arm’s length basis. None of the Company’s promoter / promoter group / group companies have any interest in the said transaction.
3.	Industry to which the entity being acquired belongs		This is a further investment. Care enablement platform which comprises of technology enabled solutions for healthcare providers.
4.	Objects and effects of acquisition (including but not limited to, disclosure of reasons for acquisition of target entity, if its business is outside the main line of business of the listed entity)		Working Capital

				Not Applicable This is a further investment. On or before October 31, 2025. Cash Consideration USD 643.19 per share No. of equity shares acquired: 15,550/- IKS Inc is a wholly owned subsidiary of the Company and with the aforesaid investment, the shareholding percentage of the Company in IKS Inc remains the same. IKS Inc. was incorporated on September 19, 2006 under the laws of the State of Delaware, USA. IKS Inc. is engaged in the business of assisting U.S. based healthcare service providers deliver better, safer, and more efficient care using a combination of outsourcing and technology. It has its principal place of business in the U.S. Amt in INR Mn Particulars FY 2024-25 FY 2023-24 FY 2022-23 Revenue from operations 6,941.11 7,027.85 6,054.66	Not Applicable This is a further investment. On or before October 31, 2025. Cash Consideration USD 643.19 per share No. of equity shares acquired: 15,550/- IKS Inc is a wholly owned subsidiary of the Company and with the aforesaid investment, the shareholding percentage of the Company in IKS Inc remains the same. IKS Inc. was incorporated on September 19, 2006 under the laws of the State of Delaware, USA. IKS Inc. is engaged in the business of assisting U.S. based healthcare service providers deliver better, safer, and more efficient care using a combination of outsourcing and technology. It has its principal place of business in the U.S. Amt in INR Mn Particulars FY 2024-25 FY 2023-24 FY 2022-23 Revenue from operations 6,941.11 7,027.85 6,054.66	Not Applicable This is a further investment. On or before October 31, 2025. Cash Consideration USD 643.19 per share No. of equity shares acquired: 15,550/- IKS Inc is a wholly owned subsidiary of the Company and with the aforesaid investment, the shareholding percentage of the Company in IKS Inc remains the same. IKS Inc. was incorporated on September 19, 2006 under the laws of the State of Delaware, USA. IKS Inc. is engaged in the business of assisting U.S. based healthcare service providers deliver better, safer, and more efficient care using a combination of outsourcing and technology. It has its principal place of business in the U.S. Amt in INR Mn Particulars FY 2024-25 FY 2023-24 FY 2022-23 Revenue from operations 6,941.11 7,027.85 6,054.66	Not Applicable This is a further investment. On or before October 31, 2025. Cash Consideration USD 643.19 per share No. of equity shares acquired: 15,550/- IKS Inc is a wholly owned subsidiary of the Company and with the aforesaid investment, the shareholding percentage of the Company in IKS Inc remains the same. IKS Inc. was incorporated on September 19, 2006 under the laws of the State of Delaware, USA. IKS Inc. is engaged in the business of assisting U.S. based healthcare service providers deliver better, safer, and more efficient care using a combination of outsourcing and technology. It has its principal place of business in the U.S. Amt in INR Mn Particulars FY 2024-25 FY 2023-24 FY 2022-23 Revenue from operations 6,941.11 7,027.85 6,054.66
	5	Brief details of any governmental or regulatory approvals required for the acquisition		Not Applicable
	6.	Indicative time period for completion of the acquisition		This is a further investment. On or before October 31, 2025.
	7.	Nature of consideration - whether cash consideration or share swap and details of the same		Cash Consideration
	8.	Cost of acquisition or the price at which the shares are acquired		USD 643.19 per share
	9.	Percentage of shareholding / control acquired and / or number of shares acquired.		No. of equity shares acquired: 15,550/- IKS Inc is a wholly owned subsidiary of the Company and with the aforesaid investment, the shareholding percentage of the Company in IKS Inc remains the same.
	10.	Brief background about the entity acquired in terms of products / line of business acquired, date of incorporation, history of last 3 years turnover, country in which the acquired entity has presence and any other significant information (in brief);		IKS Inc. was incorporated on September 19, 2006 under the laws of the State of Delaware, USA. IKS Inc. is engaged in the business of assisting U.S. based healthcare service providers deliver better, safer, and more efficient care using a combination of outsourcing and technology. It has its principal place of business in the U.S. Amt in INR Mn Particulars FY 2024-25 FY 2023-24 FY 2022-23 Revenue from operations 6,941.11 7,027.85 6,054.66
				Particulars	FY 2024-25	FY 2023-24	FY 2022-23
				Revenue from operations	6,941.11	7,027.85	6,054.66